Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 14.60
-0.30 (-2.01%)
At close: Jan 30, 2026
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €2.72 billion as of January 30, 2026. Its market cap has decreased by -51.61% in one year.
Market Cap
2.72B
Enterprise Value
2.23B
Revenue
774.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€14.60
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 2.72B, a decrease of -35.67%. That is a compound annual growth rate of -7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.72B | -20.45% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.30M |